manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa

99. Gish G. R., et al, Safety and antiviral activity of emtricitabine (FTC) for the
treatment of chronic hepatitis B infection: A two-year study, Jour of Hepatol, Ian
2005, 43(6):60-66
100. Gish G., R., et al, Ganciclovir treatment of hepatitis B virus infection in
liver transplant recipients, Hepatol, Jan 1996, 23(3):1-7
101. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of
extrahepatic manifestations. Ann Intern Med 1995; 123:615–20
102. Craxi A, Giacomo L, Zignego AL. Hepatitis C virus (HCV) infection: A
systemic disease. Mol.Aspects Med 2008; 29 (1-2): 85-95
103. Giannelli F, Moscarella S, Giannini C, Caini P, Monti M, et al. Effect of
antiviral treatment in patients with chronic HCV infection and t(14;18)
translocation. Blood 2003; 102: 1196-201
104. Misiani, R Bellavita P, Fenili D. Interferon alpha-2a therapy in
cryoglobulinemia associated with hepatitis C virus. NEJM 1994; 330:751–6
105. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic
manifestations of the Hepatitis C Virus infection: a general overview and
guidelines for clinical approach. Dig Liver Dis 2007; 39: 2-17
106. Choo QL, Kuo G, Weiner AJ et al. Isolation of cDNA clone derived from
a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359–62
107. Trejo O, Ramos-Casals M, García-Carrasco M et al. Cryoglobulinemia:
Study of etiologic factors and clinical and immunologic features in 443 patients
from a single center. Medicine (Baltimore) 2001; 80:252–62
108. Agnello V. Therapy for cryoglobulinemia secondary to hepatitis C virus:
The need for tailored protocols and multiclinic studies. J Rheumatol 2000; 27:9–
11
109. Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis.
Implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002;
46:585–97
110. Bonomo L, Casato M, Afeltra A. Treatment of idiopathic mixed
cryoglobulinemia with alpha interferon. Am J Med 1987; 83:726–30
111. Dammacco F, Sansonno D, Han JH et al. Natural interferon alfa versus its
combination with 6-methyl-prednisolone in therapy of type II mixed
cryoglobulinemia: A long term, randomized, controlled study. Blood 1994;
84:3336–43
112. Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative
glomerulonephritis associated with hepatitis C virus infection. NEJM 1993;
328:465–70
113. Agnello V, Chung R, Kaplan L. A role for hepatitis C virus infection in
type II cryoglobulinemia. NEJM 1992; 327:1490–5
114. Rockstroh JK, Spengler U, Sundho T et al. Immuno-suppression may lead
to progression of hepatitis C virus (HCV) associated liver disease in HIV–HCV
co-infected hemophiliacs. Am J Gastroenterol 1996;91:2563–8
115. Ferri C., Zignego A. L. , D. Giuggioli et al. HCV and cryoglobulinemic
vasculitis.Clev Clin Journ of Med;69, suppl II